165 related articles for article (PubMed ID: 23665899)
1. Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors.
Zhong H; Huang W; He G; Peng C; Wu F; Ouyang L
Int J Mol Sci; 2013 May; 14(5):9947-62. PubMed ID: 23665899
[TBL] [Abstract][Full Text] [Related]
2. Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.
Ouyang L; He G; Huang W; Song X; Wu F; Xiang M
Int J Mol Sci; 2012; 13(5):5348-5363. PubMed ID: 22754301
[TBL] [Abstract][Full Text] [Related]
3. The molecular mechanism studies of chirality effect of PHA-739358 on Aurora kinase A by molecular dynamics simulation and free energy calculations.
Cheng Y; Cui W; Chen Q; Tung CH; Ji M; Zhang F
J Comput Aided Mol Des; 2011 Feb; 25(2):171-80. PubMed ID: 21222017
[TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
5. Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
Betari N; Sahlholm K; Ishizuka Y; Teigen K; Haavik J
Future Med Chem; 2020 Aug; 12(16):1461-1474. PubMed ID: 32752885
[No Abstract] [Full Text] [Related]
6. Inhibition of serotonin synthesis: A novel therapeutic paradigm.
Bader M
Pharmacol Ther; 2020 Jan; 205():107423. PubMed ID: 31629717
[TBL] [Abstract][Full Text] [Related]
7. Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2016 Feb; 26(4):1124-9. PubMed ID: 26821821
[TBL] [Abstract][Full Text] [Related]
8. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
[TBL] [Abstract][Full Text] [Related]
9. Exploring binding modes of the selected inhibitors to phosphodiesterase delta by all-atom molecular dynamics simulations and free energy calculations.
Zhong H; Zhang YJ; Shan XB
J Biomol Struct Dyn; 2019 Jun; 37(9):2415-2429. PubMed ID: 30052144
[TBL] [Abstract][Full Text] [Related]
10. Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors.
Goldberg DR; De Lombaert S; Aiello R; Bourassa P; Barucci N; Zhang Q; Paralkar V; Stein AJ; Valentine J; Zavadoski W
Bioorg Med Chem Lett; 2016 Jun; 26(12):2855-2860. PubMed ID: 27146606
[TBL] [Abstract][Full Text] [Related]
11. The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.
Feng TT; Zhang YJ; Chen H; Fan S; Han JG
J Biomol Struct Dyn; 2016; 34(3):517-28. PubMed ID: 25933061
[TBL] [Abstract][Full Text] [Related]
12. Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors.
Zhou H; Wang C; Ye J; Chen H; Tao R
Gene; 2017 Dec; 637():63-71. PubMed ID: 28939339
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.
Shi H; Cui Y; Qin Y
Chem Biol Drug Des; 2018 Jan; 91(1):202-212. PubMed ID: 28719094
[TBL] [Abstract][Full Text] [Related]
14. Computational determination of binding structures and free energies of glucose 6-phosphate dehydrogenase with novel steroid inhibitors.
Zhao ZB; Liu Y; Yao Y
J Mol Graph Model; 2014 Jun; 51():168-72. PubMed ID: 24929815
[TBL] [Abstract][Full Text] [Related]
15. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
Karami L; Saboury AA; Rezaee E; Tabatabai SA
Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
[TBL] [Abstract][Full Text] [Related]
17. Binding mechanism of CDK5 with roscovitine derivatives based on molecular dynamics simulations and MM/PBSA methods.
Dong K; Wang X; Yang X; Zhu X
J Mol Graph Model; 2016 Jul; 68():57-67. PubMed ID: 27371933
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations and MM/GBSA methods to investigate binding mechanisms of aminomethylpyrimidine inhibitors with DPP-IV.
Desheng L; Jian G; Yuanhua C; Wei C; Huai Z; Mingjuan J
Bioorg Med Chem Lett; 2011 Nov; 21(22):6630-5. PubMed ID: 21996517
[TBL] [Abstract][Full Text] [Related]
19. Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
Jin H; Cianchetta G; Devasagayaraj A; Gu K; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; David Kimball S; Main AJ; Ding ZM; Sun W; Yang Q; Yu XQ; Powell DR; Wilson A; Liu Q; Shi ZC
Bioorg Med Chem Lett; 2009 Sep; 19(17):5229-32. PubMed ID: 19631532
[TBL] [Abstract][Full Text] [Related]
20. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
